M2c Macrophages Protect Mice from Adriamycin-Induced Nephropathy by Upregulating CD62L in Tregs

Junyu Lu1, Shengqiu Lv1, Jielong Pang2

  • 1Intensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China.

Mediators of Inflammation
|October 20, 2022
PubMed

Insights

M2c macrophages enhance kidney protection by upregulating CD62L in regulatory T cells (Tregs), promoting their migration to inflammatory sites. This mechanism offers insights for treating chronic kidney disease.

Area of Science:

  • Immunology
  • Nephrology
  • Cell Biology

Background:

  • Regulatory T cells (Tregs) and M2c macrophages show therapeutic potential in adriamycin-induced nephropathy (AN).
  • M2c macrophages may protect kidneys by increasing Treg numbers in renal draining lymph nodes, but the mechanism is unknown.

Purpose of the Study:

  • To investigate the mechanism by which M2c macrophages induce Treg migration in a mouse model of chronic kidney disease.

Main Methods:

  • Utilized an adriamycin-induced nephropathy (AN) mouse model.
  • Employed flow cytometry to analyze Treg migration and chemokine receptor/adhesion molecule expression.
  • Administered anti-CD62L antibody to assess its impact on cell migration.

Main Results:

  • M2c macrophages promoted Treg migration from blood to spleen, thymus, kidney, and lymph nodes.
  • M2c macrophages upregulated CCR4, CCR5, CCR7, CXCR5, and CD62L in Tregs.
  • Anti-CD62L antibody treatment inhibited M2c macrophage and Treg migration to key organs.

Conclusions:

  • M2c macrophages upregulate CD62L on Tregs, facilitating their migration to inflammatory sites for renoprotective effects.
  • This study elucidates a novel mechanism for M2c macrophage-mediated Treg recruitment in kidney disease.
  • Findings may inform the development of novel therapies for chronic kidney disease.

Related Concept Videos